14231-45-9

Usage

Uses

Used in Biochemical Research:
(Phenoxyacetyl)amino]acetic Acid is used as a research compound for understanding its interactions and potential applications in biochemical processes.
Used in Pharmaceutical Development:
(Phenoxyacetyl)amino]acetic Acid is used as a key component in the development of pharmaceutical compounds, leveraging its stability and efficiency in various chemical reactions.
Used in Chemical Reactions:
(Phenoxyacetyl)amino]acetic Acid is used as a solvent in various chemical reactions, taking advantage of the strong, pungent properties of Acetic acid.
Used in Pesticides and Herbicides:
(Phenoxyacetyl)amino]acetic Acid is used as an active ingredient in the formulation of pesticides and herbicides, due to the stability and efficiency of Phenoxyacetyls.

InChI:InChI=1/C10H11NO4/c12-9(11-6-10(13)14)7-15-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14)/p-1

Upstream product

• 701-99-5 Phenoxyacetyl chloride 
• 56-40-6 glycine 

Downstream Products

• 101067-70-3 N-[(3S,4R)-1-(2-Hydroxy-2-phenyl-ethyl)-2-oxo-4-phenyl-azetidin-3-yl]-2-phenoxy-acetamide 
• 101067-71-4 N-[(2R,3S)-1-(2-Hydroxy-2-phenyl-ethyl)-2-(4-methoxy-phenyl)-4-oxo-azetidin-3-yl]-2-phenoxy-acetamide 
• 17080-28-3 N-phenoxyacetyl-glycine 4-nitro-phenyl ester 
• 141736-41-6 1-phenyl-2-methylphenoxy-4-(p-bis-β-cyanoethylaminobenzylidene)-5-imidazolone 
• 141736-43-8 3-((2-Cyano-ethyl)-{4-[5-oxo-2-phenoxymethyl-1-m-tolyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 
• 141736-42-7 3-((2-Cyano-ethyl)-{4-[5-oxo-2-phenoxymethyl-1-o-tolyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 
• 141736-34-7 3-((2-Cyano-ethyl)-{4-[5-oxo-2-phenoxymethyl-1-p-tolyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 
• 141736-36-9 3-[{4-[1-(4-Chloro-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-(2-cyano-ethyl)-amino]-propionitrile 
• 141736-48-3 3-[{4-[1-(4-Bromo-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-(2-cyano-ethyl)-amino]-propionitrile 
• 141736-46-1 3-[{4-[1-(2-Chloro-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-(2-cyano-ethyl)-amino]-propionitrile 
• 141736-47-2 3-[{4-[1-(3-Chloro-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-(2-cyano-ethyl)-amino]-propionitrile 
• 141736-45-0 3-((2-Cyano-ethyl)-{4-[1-(3-methoxy-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 
• 141736-35-8 3-((2-Cyano-ethyl)-{4-[1-(4-methoxy-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 
• 141736-44-9 3-((2-Cyano-ethyl)-{4-[1-(2-methoxy-phenyl)-5-oxo-2-phenoxymethyl-1,5-dihydro-imidazol-(4E)-ylidenemethyl]-phenyl}-amino)-propionitrile 

Relevant academic research and scientific papers

The use of cellulose (chromatography paper) as a cheap, versatile and non-covalent support for organic molecules during multi-step synthesis

Cellulose chromatography paper provides a novel non-covalent support for synthesis and in-situ purification of multi-dimensional arrays.

Iodide Dealkylation of Benzyl, PMB, PNB, and t-Butyl N-Acyl Amino Acid Esters via lithium Ion Coordination

Lithium iodide promotes ester dealkylation in compounds containing an amide carbonyl in the γ-position to the ester carbonyl, as is found in N-acyl amino acid esters.Activation of the ester carbonyl via lithium ion coordination is facilatated by aprotic non-polar solvents such as THF and EtOAc.This process is not limited to methyl esters but readily dealkylates benzyl, PMB, PNB, and t-butyl esters and is espesially suitable for use with β-lactam esters because of the mild conditions. - Key Words: ester dealkylation; deesterification; lithium iodide; N-acyl amino acid esters; beta-lactams.

Bicycloheptane substituted diamide and its congener prostaglandin analogs

Bicycloheptane substituted amide prostaglandin analogs are provided having the structural formula STR1 wherein m is 0 to 4; A is --CH=CH-- or --CH2 --CH2 --; n is 1 to 5; Q is --CH=CH--, --CH2 --, STR2 or a single bond; R is CO2 H, CO2 alkyl, CO2 alkali metal, CO2 polyhydroxyamine salt, --CH2 OH, STR3 wherein R4 and R5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R4 and R5 being other than hydroxy and lower alkoxy; p is 1 to 4; R1 is H or lower alkyl; q is 1 to 12; R2 is H or lower alkyl; and R3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, lower alkyl-S-, aryl-S-, arylalkyl-S-, STR4 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

7-oxabicycloheptane substituted hydroxamic acid prostaglandin analogs

7-Oxabicycloheptane substituted hydroxamic acid prostaglandin analogs are provided having the structural formula STR1 wherein A is --CH=CH-- or --CH2 -CH2 --; n is 1 to 5; R is CO2 H, CO2 alkyl, CO2 a

5,6-epoxy-7-oxabicycloheptane substituted diamide prostaglandin analogs

5,6-Epoxy-7-oxabicycloheptane substituted diamide prostaglandin analogs are provided having the structural formula STR1 wherein A is --CH=CH-- or --CH2 --CH2 --; n is 1 to 5; R is CO2 H, CO2 alkyl, CO2 alkali metal, CO2 polyhydroxyamine salt or STR2 q is 1 to 12; and R1 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, STR3 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

7-thiabicycloheptane substituted diamide and its congener prostaglandin analogs

7-Thiabicycloheptane substituted diamide and congener prostaglandin analogs are provided having the structural formula STR1 wherein m is 1 to 4; A is --CH=CH-- or --CH2 --CH2 --; n is 1 to 5; R is CO2 H, CO2 alkyl, CO2 alkali metal, CO2 polyhydroxyamine salt, --CH2 OH, STR2 wherein R3 and R4 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R3 and R4 being other than hydroxy and lower alkoxy; p is 1 to 4; Z is STR3 q is 1 to 12; R1 is H or lower alkyl; and R3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, STR4 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

7-OXABICYCLOHEPTANE SUBSTITUTED DIAMIDE AND ITS CONGENER PROSTAGLANDIN ANALOGS USEFUL IN THE TREATMENT OF THROMBOTIC DISEASE

7-Oxabicycloheptane substituted amide prostaglandin analogs are provided having the structural formula STR1 wherein m is 0 to 4; A is--CH=CH--or--CH 2--CH 2--; n is 1 to 5; Q is--CH=CH--,--CH 2--, STR2 or a single bond; R is CO 2 H, CO 2 alkyl, CO 2 alkali metal, CO 2 polyhydroxyamine salt,--CH 2 OH, STR3 wherein R. sup.4 and R 5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R 4 and R 5 being other than hydroxy and lower alkoxy; p is 1 to 4; R. sup.1 is H or lower alkyl; q is 1 to 12; R 2 is H or lower alkyl; and R 3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, STR4 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl.The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.